5 completed, 1 terminated, 1 withdrawn. 7 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 7 | Completed 5, Terminated 1, Withdrawn 1 |
| Phase 2 | 1 | Withdrawn 1 |
Follow Prolong Pharmaceuticals: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety Study of PP-007 in Subjects With Acute Ischemic Stroke PP-007 (Two doses administered 24±6 hours apart) + SOC (IVT or MT or IVT+MT) - Acute Ischemic Stroke | Phase 1 | Completed | Prolong Pharmaceuticals | 24 | 2024-04-24 | 2025-11-14 |
| A Study of EPEG in Beta Thalassemia Patients EPEG - Beta-Thalassemia | Phase 1 | Completed | Prolong Pharmaceuticals | 6 | 2017-06-28 | 2018-05-25 |
| A Phase 1 Safety Study of SANGUINATE™ In Patients With Acute Severe Anemia. SANGUINATE™ - Acute Anemia | Phase 1 | Completed | Prolong Pharmaceuticals | 103 | 2016-03-01 | 2017-06-27 |
| ANF-Rho in the Treatment of Chronic Neutropenia ANF-Rho - Neutropenia, Severe Chronic | Phase 1 / Phase 2 | Withdrawn | Prolong Pharmaceuticals | 2015-10-01 | 2019-03-06 | |
| Study to Assess the Safety and Impact on Humoral Sensitization of SANGUINATE in Patients With End Stage Renal Disease SANGUINATE - Renal Insufficiency, Chronic | Phase 1 | Completed | Prolong Pharmaceuticals | 5 | 2015-06-05 | 2018-05-23 |
| Study of SANGUINATE™ Versus Hydroxyurea in Sickle Cell Disease (SCD) Patients SANGUINATE™, Hydroxyurea - Sickle Cell Disease | Phase 1 | Completed | Prolong Pharmaceuticals | 24 | 2013-05-01 | 2014-12-03 |
| An Assessment of the Safety and Pharmacokinetics of Ascending Doses of SANGUINATE™ in Healthy Volunteers. SANGUINATE™, Normal Saline Solution - Drug Safety | Phase 1 | Terminated | Prolong Pharmaceuticals | 2 | 2013-05-01 | 2015-01-06 |
Anemia, Sickle Cell (1) · Ischemic Stroke (1) · Neutropenia, severe chronic (1) · Renal Insufficiency, Chronic (1) · Stroke (1) · beta-Thalassemia (1)
PEGylated carboxyhemoglobin bovine (5) · Hydroxyurea (1) · Saline Solution (1)
United States (3) · Colombia (1) · Israel (1) · Panama (1) · Thailand (1)
Abe Abuchowski, PhD (1) · Angel Hernandez, MD (1) · Bassam G Abu Jadweh, MD (1) · Benjamin Brenner, MD (1) · Hemant Misra, PhD (1) · Kenny M Galvez, MD (1) · Kirsten Gruis, MD (1) · Luis F Uribe, MD (1) · Nestor Sosa, MD (1) · Rosa Real, MD (1)